We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

By HospiMedica International staff writers
Posted on 24 Feb 2026

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. More...

Although lab-grown pancreatic tissue offers a promising alternative, these cells often fail to fully mature and function like natural islets. Researchers have now developed an electronic implant system that helps lab-grown pancreatic cells develop properly, potentially advancing cell-based therapies for diabetes.

Researchers at the Perelman School of Medicine at the University of Pennsylvania (Philadelphia, USA) and the School of Engineering and Applied Sciences at Harvard University (Cambridge, USA) embedded an ultrathin, stretchable conductive mesh—thinner than a human hair—within three-dimensional pancreatic organoids. The mesh allowed continuous recording of electrical activity from developing islet cells and delivered controlled electrical stimulation patterned after natural 24-hour circadian rhythms.

The implanted mesh introduced rhythmic electrical activity that encouraged immature cells to mature and respond appropriately to glucose. After four days of stimulation, the cells maintained their cycling behavior independently. The synchronized electrical signals appeared to help individual islet cells coordinate as a functional network, improving hormone secretion timing. The approach, presented in Science, enabled researchers to observe electrical transitions over two months and revealed the importance of circadian rhythms in islet development.

The technology may support two potential therapeutic strategies: stimulating lab-grown islet cells before transplantation or leaving the mesh in place to monitor and maintain long-term function. Such systems could increase tissue supply and reduce transplant rejection risks. Researchers also envision integrating artificial intelligence to automatically monitor and regulate cell activity, potentially creating a self-regulating implant system for diabetes management.

“What we’re doing is like deep stimulation for the pancreas. Just like pacemakers help the heart keep rhythm, controlled electrical pulses can help pancreatic cells develop and function the way they’re supposed to,” said Juan Alvarez, PhD, assistant professor at Penn Medicine. “In the future, we could have a system that runs without human intervention.”

Related Links:
Penn Medicine
Harvard University School of Engineering and Applied Sciences


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.